Nuts may enhance fertility for men: study
Posted: 29 November 2023 Eating nuts may enhance male fertility, a Monash University-led research review has found. The authors now want more research into the potential benefits of nuts for male and female fertility after finding only two intervention…
2023 BioMelbourne Network AGM wrap
Posted: 24 November 2023 On Thursday 23 November, KPMG hosted 107 BioMelbourne Network members in person at the 2023 BioMelbourne Network Annual General Meeting, in Docklands. At the event, David Herd, the Board Chair, and Jeff Malone,…
First Patients Enrolled at SENTA Partners in the US
Posted: 23 November 2023 Adherium Limited (ASX: ADR), a leading digital health company specialising in remote patient monitoring and data solutions for respiratory patients, confirms the first patients have been enrolled and remote patient monitoring underway as part…
Unlocking the power of the immune system to kill prostate cancer
Posted: 23 November 2023 The Albanese Government is providing $5 million to Professor Gail Risbridger and a team from Monash University, as a grant from the National Health and Medical Research Council (NHMRC) to develop CAR T cell…
Potential new treatment for prostate cancer receives $5M funding boost
Posted: 23 November 2023 A newly funded Monash University-led research program will investigate the potential of Chimeric Antigen Receptor T (CAR T) cell therapy, previously only effective in blood cancers, for the treatment of prostate cancer. Prostate cancer…
Unlocking the power of genomics with $66 million for research
Posted: 23 November 2023 The Albanese Government is unlocking the power and potential of personalised medicine with $66 million for genomics research into a number of serious diseases and common chronic conditions. The Albanese Government is unlocking the…
Immutep Announces Site Expansion for INSIGHT-003 Phase I Trial
Posted: 23 November 2023 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces that the INSIGHT-003 trial has been expanded to four…
New Report: Actions Needed to Step Up Fight Against Superbug Pandemic Detailed
Posted: 22 November 2023 A new report from MTPConnect and its Australian Antimicrobial Resistance Network (AAMRNet) highlights the threat to human health posed by the rise of drug-resistant infections and presents recommendations that will equip the Australian healthcare…
Snow Centre for Immune Health to revolutionise global immunology research
Posted: 21 November 2023 The Snow Medical Research Foundation (Snow Medical) will establish one of the world’s leading immunology research centres at WEHI through a partnership with an initial commitment of $100 million over 10 years – one of the…
CSIRO study identifies AI models to improve automated chest X-ray diagnoses
Posted: 21 November 2023 New research from CSIRO, Australia’s national science agency, has identified methods for improving artificial intelligence (AI) diagnosis of heart and lung conditions using X-ray. In a recently published paper, scientists from CSIRO’s Australian e-Health Research…
4DMedical receives U.S. FDA clearance for CT LVAS
Posted: 21 November 2023 Respiratory imaging technology company 4DMedical Limited (ASX:4DX, “4DMedical”, or the “Company”) today announces that it has received clearance for its CT-based ventilation product (CT LVAS™) from the U.S. Food and Drug Administration (FDA). CT…
University of Melbourne unveils six start ups, announces $4.5M investment in company developing psychedelic-assisted therapies
Posted: 17 November 2023 The University of Melbourne has unveiled a cohort of six early-stage startups and announced the first syndicated investment of $4.5 million by the University’s Genesis Pre-Seed Fund and Tin Alley Ventures into a start-up…
